Nat Aging 润色咨询

Nature Aging

出版年份:2021 年文章数:95 投稿命中率: 开通期刊会员,数据随心看

出版周期:monthly 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2024-05-07 ms7000000703176276 来自广东省

    投稿第9天,看了大家经验感觉机会渺茫。。。

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2022-01-25 ms2893900752900076

    这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。

    10

    展开10条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2024-05-10 ms7000000703176276 来自广东省

    偏重的研究方向:衰老;抗衰老
    经验分享:投稿12天状态未变化

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2024-05-10 ms7000000703176276 来自广东省

    投稿12天了,还在consideration,机会渺茫啊😭

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2023-06-29 ms6000002144421454 来自上海

    偏重的研究方向:衰老;老年性痴呆
    经验分享:请问这个期刊从投出到返修需要多久

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2023-07-26 ms1000000582868380 来自浙江省

    投稿命中率:5.0
    偏重的研究方向:衰老
    经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2024-04-14 ms2000000842899520 来自广东省

    123

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2023-12-23 侠胆医心 来自威斯康星

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:衰老;老年病学;抗衰老
    经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2023-04-19 侠胆医心 来自香港

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:衰老;老年性痴呆;退行性病变
    经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2202121, encodeId=eb8c220212151, content=投稿第9天,看了大家经验感觉机会渺茫。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Tue May 07 08:56:44 CST 2024, time=2024-05-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1187959, encodeId=6336118e959a1, content=这个期刊编辑有问题,随便找两篇和你研究不相关文献,说你创新性不足,拒你。小课题组慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b20a1875199, createdName=ms2893900752900076, createdTime=Tue Jan 25 10:20:49 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204002, encodeId=b9e3220400230, content=偏重的研究方向:衰老;抗衰老<br>经验分享:投稿12天状态未变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:23:49 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204000, encodeId=80442204000e0, content=投稿12天了,还在consideration,机会渺茫啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbc75611325, createdName=ms7000000703176276, createdTime=Fri May 10 23:12:38 CST 2024, time=2024-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145558, encodeId=786e2145558a8, content=偏重的研究方向:衰老;老年性痴呆<br>经验分享:请问这个期刊从投出到返修需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10745538240, createdName=ms6000002144421454, createdTime=Thu Jun 29 23:09:40 CST 2023, time=2023-06-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150001, encodeId=5fb5215000130, content=投稿命中率:5.0<br>偏重的研究方向:衰老<br>经验分享:在影响因子普遍回落的2022 nature aging首个IF就达到16.6,投稿难度已经是nature大子刊阶梯,要求非常高,后面IF必然二三十分 衰老领域稿件要求远远超过老牌期刊aging cell, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aff5496691, createdName=ms1000000582868380, createdTime=Wed Jul 26 21:22:27 CST 2023, time=2023-07-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198438, encodeId=09332198438bb, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a29248593, createdName=ms2000000842899520, createdTime=Sun Apr 14 12:01:27 CST 2024, time=2024-04-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2176650, encodeId=b1a821e665093, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:衰老;老年病学;抗衰老<br>经验分享:期刊在2023年公布的JCR(期刊印证报告)中作为ESCI期刊被收录,获得了16.6的影响因子。在此次12月WOS更新后,该期刊被SCI期刊目录收录,晋级成为SCI期刊(不再被ESCI数据库收录)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Dec 23 07:28:13 CST 2023, time=2023-12-23, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2126980, encodeId=05492126980f4, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:衰老;老年性痴呆;退行性病变<br>经验分享:虽然是新刊,实际上不少文章都是从Nature主刊拒稿转投过来的,整体质量还是很高。想发表确实得拼创新,数据。尤其这几年衰老领域发展太快,竞争激烈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 19 10:03:49 CST 2023, time=2023-04-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2117784, encodeId=5aa4211e7849d, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享:很专业,非常难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ada04876890, createdName=15944a2fc4m, createdTime=Sun Mar 05 20:19:33 CST 2023, time=2023-03-05, status=1, ipAttribution=江苏省)]
    2023-03-05 15944a2fc4m 来自江苏省

    审稿速度:6.0 | 投稿命中率:5.0
    经验分享:很专业,非常难

    0

共32条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分